The Abbott Park, Ill., pharmaceuticals giant also issued in-line guidance for the year.
Abbott made $716 million, or 46 cents a share, for the quarter ended Sept. 30, up from the year-ago $681 million, or 44 cents a share. Excluding certain costs, latest-quarter earnings were 58 cents a share, flat with a year ago and matching the Thomson Financial analyst consensus estimate.
Sales rose 3.5% from a year ago to $5.57 billion, beating the $5.48 billion Wall Street target.
The company said it expects to make around 74 cents a share for the fourth quarter and $2.51 or so for the year, matching the Thomson Financial estimates.